Vivani Medical, Inc. Common Stock (DE)

VANI

Vivani Medical, Inc. (VANI) is a biotechnology company focused on developing innovative solutions for the treatment of chronic conditions. The firm specializes in advanced drug delivery systems and regenerative medicine technologies aimed at improving patient outcomes and quality of life.

$1.32 -0.01 (-0.74%)
🚫 Vivani Medical, Inc. Common Stock (DE) does not pay dividends

Company News

Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream
GlobeNewswire Inc. • Emerginggrowth.Com • July 14, 2026

EmergingGrowth.com announces the 94th Emerging Growth Conference scheduled for July 15-16, 2026, featuring presentations from 20+ small-cap and emerging growth companies across sectors including mining, technology, healthcare, and renewable energy. The virtual conference allows companies to present their strategies, products, and announcements to...

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
GlobeNewswire Inc. • Na • July 2, 2026

Vivani Medical announced a definitive merger agreement to merge its wholly owned subsidiary Cortigent, Inc. with ClearOne, Inc. Under the transaction, Cortigent will become a wholly owned subsidiary of ClearOne, which will be renamed Cortigent Holdings, Inc. and trade under ticker symbol 'CRGT'. ClearOne will raise $10-15 million in concurrent fi...

Vivani Medical, Inc. Announces Pricing of Common Stock Offering
GlobeNewswire Inc. • Na • January 26, 2026

Vivani Medical announced a registered direct offering of 1.69 million shares and concurrent private placement of 1.35 million shares at $1.48 per share, raising approximately $4.5 million gross proceeds. The funds will support ongoing research and clinical development of the company's drug implant candidates. Chairman Gregg Williams participated ...

Vivani Medical, Inc. Announces Pricing of Common Stock Offering
GlobeNewswire Inc. • Vivani Medical, Inc. • October 26, 2025

Vivani Medical is raising approximately $15.7 million through a registered direct offering of 6 million shares and a private placement of 3.7 million shares at $1.62 per share. The proceeds will fund research, clinical development, and general corporate purposes.

Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now
GlobeNewswire Inc. • Emerginggrowth.Com • January 15, 2025

EmergingGrowth.com announces the schedule for the 78th Emerging Growth Conference, featuring presentations from various companies across different growth sectors.

Related Companies